Now Accepting Proposals:
| Grant | |
Deadline | Amount |
|
|||
| Validation of Novel Combinations and Novel Compounds |
 |
Jun 30 | $200,000 |
| Biotech Investment Award (formerly LEAD) | |
Aug 1 | varies |
| Myeloma Cancer Stem Cell | |
Sep 2 | $250,000 |
The MMRF supports innovative research efforts in the most promising areas of multiple myeloma research through several grant-making programs. The MMRF accepts applications from U.S.-based and international non-profit institutions and universities. Program guidelines and applications are available approximately 6-8 weeks prior to the submission deadline.
MMRF Research Grant Awards
Significant advances in our understanding of the pathophysiology and molecular biology involved in multiple myeloma have identified numerous putative molecular targets for therapeutic intervention. The MMRF welcomes proposals on any and all multiple myeloma related topics to the traditional Research Grant Award Programs.
Special Request for Proposals (RFPs)
MMRF Research Grant Awards
Significant advances in our understanding of the pathophysiology and molecular biology involved in multiple myeloma have identified numerous putative molecular targets for therapeutic intervention. The MMRF welcomes proposals on any and all multiple myeloma related topics to the traditional Research Grant Award Programs.
-
Research Fellows Awards provide funding to researchers with less than five years experience (post graduate degree) and working under the supervision of a research sponsor. Proposals may request up to $75,000 for one year. The deadline to submit an application for the Fellows Award is March 1, 2008. Anticipated applicant notification date is early May.
The RFPs are designed to support research projects outside the scope of the MMRF's traditional Research Grants Program. These special funding opportunities are created to address critical research needs and to advance important research and drug discovery efforts. Programs are subject to funding availability and may change throughout the year.
-
Validation of Novel Combinations and Novel Compounds With a multitude of therapeutic options under investigation for multiple myeloma, the ability to identify those that show the most potential in treating the disease is of critical importance. One of the most effective and efficient ways to do this is through is pre-clinical validation. These awards were developed to advance the science of pre-clinical validation in multiple myeloma.
-
Novel combination therapies and the sequencing of these therapies hold tremendous promise in treating multiple myeloma. The Validation of Novel Combinations proposals should support the testing of several targeted therapeutic agents — either novel or currently available compounds — in innovative, rationally–designed combinations and sequences. Proposals may request up to $200,000 over the course of two years. The deadline to submit an application is June 30, 2008 and applicants will be notified in September.
-
BIA Award (formerly LEAD): The Multiple Myeloma Research Foundation (MMRF) seeks proposals for its Biotech Investment Award program (BIA). The goal of this initiative is to drive and accelerate the development of innovative and effective treatments for myeloma. This program is designed to: a) provide resources necessary for biotechnology and pharmaceutical companies to rapidly test therapeutics in multiple myeloma; and b) to foster collaboration with academic myeloma experts, as needed. BIA aims to remove barriers that limit the development of novel drugs for myeloma. This is a milestone-driven initiative. Payments will be made after successful completion of milestones as outlined in each applicant's proposal.
-
Myeloma Cancer Stem Cell: The Multiple Myeloma Research Foundation (MMRF) and the Leukemia & Lymphoma Society (LLS) are co-sponsoring and issuing this Request for Application (RFA) in order to encourage application of the emerging field of cancer stem cell biology to Multiple Myeloma (MM). The MMRF and LLS will co-sponsor two awards. Each award will amount to $250,000 over a two year period. Applications should be submitted through the proposalCENTRAL Application System.
MMRF Accreditations
American Institute of Philanthropy
Charity Navigator
Best in America Seal
BBB Wise Giving Alliance
